InterMune (nasdaq)ITMN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : InterMune (nasdaq)ITMN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Secret_Agent_Man who started this subject	5/25/2001 3:05:06 PM
From: IRWIN JAMES FRANKEL	Read Replies (1) of 508

Intermune to Present at UBS Warburg Global Specialty Pharmaceutical Conference May 18, 2001 06:00:00 AM ET BURLINGAME, Calif., May 18 /PRNewswire/ -- InterMune ITMN announced that its presentation to the UBS Warburg Global Specialty Pharmaceutical Conference can be heard live through a listen-only telephone conference line by calling 888-515-2781 or 719-457-2605. The presentation will also be available as a telephone recording following the conference by calling 800-759-8603 or 402-220-8537. W. Scott Harkonen, M.D., President and CEO of InterMune, will be speaking at The Pierre Hotel in New York, New York on Tuesday, May 22, 2001 at 10:00 a.m.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next